Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

July 20, 2022

Marlborough medical device manufacturer files for irregular heartbeat treatment patent

Courtesy CardioFocus The CardioFocus treatment uses a steerable sheath.

CardioFocus, Inc. has filed for key patents for its technology designed to treat atrial fibrillation, which is a type of abnormal heartbeat.

Earlier this year, the Marlborough medical device manufacturer filed the patent for its HeartLight System pulse field ablation technology, which is designed to maintain contact with a vein important to maintaining a regular heartbeat.

The company expects the technology to have its first human use in 2023, according to a Tuesday press release from the company.

“We believe HeartLight enables best-in-class patient results by providing an ablation platform that will facilitate the creation of precise lesions and thereby predictable, efficient cases,” CardioFocus CEO & President Burke Barrett said in the press release. “We are thrilled by the patient outcomes and the excitement we have seen with our HeartLight X3 laser-based therapy.”
 

Sign up for Enews

WBJ Web Partners

0 Comments

No More articles left

To read more, please
Login or Register (free)

 

To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy

Allow Cookies